BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2019
View Archived Issues
DNA damage repair protein Mus81 promotes migration of gastric cancer through regulation of ZEB1
Read More
TWEAK/Fn14 is upregulated in Crohn's disease and has a key pathogenic role in ileitis mouse models
Read More
Xeris initiates dosing in phase II study of fixed-ratio coformulation of pramlintide and insulin
Read More
A pancreatic (pro)enzyme mixture shows high efficacy against human pancreatic cancer stem cells
Read More
CAFs 'educated' by GoF p53-mutant pancreatic cancer cells promote metastasis and chemoresistance
Read More
Novel glomerulus-on-a-chip for renal disease modeling and drug testing
Read More
Boehringer and Inflammasome partner to develop novel therapies for retinal diseases
Read More
CStone announces clinical data for CS-1001, CS-1002 and CS-1003
Read More
FDA approves Pifeltro and Delstrigo for virologically suppressed adults with HIV-1 infection
Read More
Phase I data presented from the phase I/II STERIMGLI trial of durvalumab plus hFSRT
Read More
Rottapharm Biotech presents CR-13626, an oral tyrosine kinase inhibitor for the treatment of GBM
Read More
Karyopharm presents promising phase II safety and efficacy data for selinexor in rGBM
Read More
Lenti-D demonstrates the ability to stabilize neurologic disease progression in phase II/III study
Read More
Novartis discovers new endonucleases inhibitors
Read More
Reaction Biology Corp. describes HDAC/SIRT inhibitors
Read More
U.S. Department of Defense awards research grant to Novan
Read More
New PD-1 inhibitors disclosed by Bristol-Myers Squibb
Read More
Finding a balance in treating diabetic kidney damage
Read More
Beijing Scitech-Mq Pharmaceuticals patents wild-type EGFR, EGFR T790M mutant and HER2 inhibitors
Read More
DeNovaMed identifies bacterial acyl carrier protein synthase inhibitors
Read More
GenSight reports week 96 data from phase III RESCUE trial of GS-010 in LHON
Read More
FDA approves Rybelsus for type 2 diabetes
Read More
Immune responses, tumor reductions observed with Bria-IMT and pembrolizumab in phase I/IIa study
Read More
Phase IIa study assesses efficacy of vivax malaria vaccines ChAd63 PvDBP and MVA PvDBP
Read More
Syndax initiates phase I/II study of SNDX-5613 in relapsed or refractory leukemias
Read More
Crysvita approved in Japan for FGF-23-related hypophosphatemic rickets and osteomalacia
Read More
